BSE Live
Oct 01, 16:01Prev. Close
14621.75
Open Price
14325.05
Bid Price (Qty.)
15300.00 (2)
Offer Price (Qty.)
15387.20 (1)
NSE Live
Oct 01, 15:53Prev. Close
14605.00
Open Price
14700.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Neuland Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | |
Total Share Capital | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | |
Reserves and Surplus | 1,504.05 | 1,262.80 | 974.63 | 821.83 | 768.14 | |
Total Reserves and Surplus | 1,504.89 | 1,263.64 | 975.46 | 822.67 | 768.98 | |
Total Shareholders Funds | 1,517.79 | 1,276.54 | 988.36 | 835.57 | 781.88 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 90.73 | 44.92 | 74.25 | 104.25 | 88.13 | |
Deferred Tax Liabilities [Net] | 71.56 | 59.34 | 57.30 | 11.45 | 59.00 | |
Other Long Term Liabilities | 18.62 | 9.20 | 3.85 | 62.72 | 12.45 | |
Long Term Provisions | 6.64 | 7.13 | 9.83 | 0.00 | 9.10 | |
Total Non-Current Liabilities | 187.54 | 120.59 | 145.22 | 178.42 | 168.68 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 45.28 | 37.59 | 47.26 | 126.70 | 56.98 | |
Trade Payables | 260.90 | 198.54 | 177.99 | 117.54 | 156.75 | |
Other Current Liabilities | 164.55 | 196.04 | 218.97 | 122.68 | 158.59 | |
Short Term Provisions | 2.10 | 1.64 | 1.53 | 1.21 | 0.64 | |
Total Current Liabilities | 472.84 | 433.80 | 445.75 | 368.13 | 372.96 | |
Total Capital And Liabilities | 2,178.17 | 1,830.93 | 1,579.34 | 1,382.12 | 1,323.52 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 673.69 | 522.71 | 457.43 | 466.12 | 413.97 | |
Intangible Assets | 281.20 | 281.92 | 280.76 | 281.58 | 282.96 | |
Capital Work-In-Progress | 44.55 | 45.89 | 40.57 | 20.46 | 17.25 | |
Other Assets | 0.00 | 19.03 | 19.34 | 19.66 | 18.91 | |
Fixed Assets | 1,002.55 | 869.55 | 798.10 | 787.82 | 733.08 | |
Non-Current Investments | 1.69 | 1.44 | 0.68 | 0.66 | 0.60 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 36.11 | 40.48 | 20.21 | 12.42 | 41.66 | |
Total Non-Current Assets | 1,040.35 | 911.46 | 819.00 | 800.89 | 775.34 | |
CURRENT ASSETS | ||||||
Current Investments | 107.68 | 0.00 | 0.00 | 3.38 | 6.46 | |
Inventories | 385.76 | 350.42 | 279.23 | 265.21 | 247.61 | |
Trade Receivables | 315.72 | 373.53 | 361.77 | 234.33 | 217.73 | |
Cash And Cash Equivalents | 257.27 | 115.29 | 58.65 | 18.99 | 18.08 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 71.39 | 80.23 | 60.69 | 59.33 | 58.30 | |
Total Current Assets | 1,137.82 | 919.47 | 760.34 | 581.23 | 548.18 | |
Total Assets | 2,178.17 | 1,830.93 | 1,579.34 | 1,382.12 | 1,323.52 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 92.22 | 140.47 | 100.72 | 92.99 | 127.52 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 205.92 | 179.47 | 180.41 | 161.28 | 276.48 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 998.39 | 1,175.49 | 875.00 | 685.80 | 729.19 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | 0.25 | -- | |
Non-Current Investments Unquoted Book Value | 1.69 | 1.44 | 0.41 | 0.41 | 0.41 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 100.00 | -- | -- | 3.38 | 6.46 |
15.09.2025
01.08.2025
Neuland Lab Consolidated June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
Neuland Lab Standalone June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
01.08.2025
Neuland Lab Consolidated June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
Neuland Lab Standalone June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
16.05.2025
Neuland Lab Consolidated March 2025 Net Sales at Rs 328.36 crore, down 14.71% Y-o-Y
15.05.2025
Neuland Lab Standalone March 2025 Net Sales at Rs 328.36 crore, down 14.71% Y-o-Y